NCT07340437Completed
Clinical Study of 18F-Exendin-4 in Insulinoma
Clinical Study of an ¹⁸F-labeled GLP-1R Probe in Insulinoma
Source: ClinicalTrials.gov · Last updated 15 Jan 2026
Brief summary (registry, in English)
The goal of this observational study is to evaluate the diagnostic value of ¹⁸F-Exendin-4 PET/CT imaging in renal insulinoma. Participants will undergo clinical evaluation and ¹⁸F-Exendin-4 PET/CT examination.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 20 (actual)
- First submitted
- 6 Jan 2026
- Start date
- 1 Feb 2023
- Primary completion date
- 31 Oct 2025
- Lead sponsor
- Sichuan Provincial People's Hospital
- NCT number
- NCT07340437
What you commit to
- Study type: Observational
- Participants enrolled: 20
- From 1 Feb 2023 to the primary completion date, 31 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients clinically diagnosed with insulinoma but without subsequent surgical intervention or biopsy
Other
- unknown etiology of hypoglycemia at last follow-up
Who the study is looking for
- biochemically confirmed hyperinsulinemic hypoglycemia (plasma glucose \< 3.0 mmol/L, insulin \> 3 μIU/mL, C-peptide \> 0.6 ng/mL)
- surgical or biopsy-confirmed insulinoma or non-insulinoma pancreatogenous hypoglycemia syndrome, with definitive clinical diagnosis at discharge and comprehensive evaluation for hypoglycemia etiology during hospitalization.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Endocrinology and Department of Nuclear Medicine, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072 Coordinator of this site? Confirm its status | Chengdu | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.